Merck KGaA buys Bangalore firm; Sinovac flu shot nabs Hong Kong OK;

> Merck Specialities Private Ltd., an Indian subsidiary of Merck KGaA, has acquired the Indian bioscience firm Bangalore Genei for an undisclosed sum. Report

> China's Sinovac won Hong Kong approval for its PanFlu vaccine against H1N1 flu and plans to submit more shots for approval in the country.Report

> A long-term study demonstrated the benefits of combining GlaxoSmithKline's Avodart and tamsulosin in the treatment of men with benign prostatic hyperplasia. Report

> A CSL Behring drug, Berinert, got the FDA nod as a treatment for hereditary angioedema. Report

> Merck's combination diabetes treatment Janumet won approval for marketing in Canada. Report

> Former Genentech chief Arthur Levinson resigned from Google's board of directors, likely because he wanted to allay concerns of a conflict of interest with his role on Apple's board. Report

> GlaxoSmithKline Malaysia expects sales for its pharmaceutical sector to grow 6 percent to 8 percent next year. Report

Biotech News

> GlaxoSmithKline has committed up to $680 in upfront fees and milestones to team with the Dutch biotech Prosensa on a package of four RNA programs aimed at Duchenne Muscular Dystrophy. Report

> Cambridge, MA-based Dyax has grown a lot closer to Sanofi-Aventis in recent weeks. Article

> Delisted by Nasdaq, stymied by the FDA on its lead cancer product and suffering from a cash crunch, Vion Pharmaceuticals has brought in the investment banking firm Merriman Curhan Ford & Co. to help ponder its options. Report

Research News

> GSK is backing a $60M biotech science cluster in the UK. Report

> In a breakthrough, scientists have crafted a key part of a human jaw bone from stem cells and say the same process they used can be used to repair all types of bones in the human body. Item

> New sequencing technology has helped researchers analyze the DNA of a breast cancer genome from a single patient at three different stages of development, offering scientists a revealing look at how breast cancer cells mutate as the disease develops. Article

> Scientists have successfully treated diabetes with resveratrol. Report

> A single retrovirus appears to be prime culprit for chronic fatigue. Article

And Finally... Women whose breasts became tender after taking hormone replacement therapy had nearly twice the risk of developing breast cancer, researchers found. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.